Nifty
:
23587.50
Sensex
:
78041.59
-364.20 (-1.52%)
-1176.46 (-1.49%)
Nifty
Sensex
:
:
23587.50
78041.59
-364.20 (-1.52%)
-1176.46 (-1.49%)

Zim Laboratories Ltd.

Pharmaceuticals & Drugs

Rating :
N/A

BSE: 541400 | NSE: ZIMLAB

NSE BSE
108.77
20-Dec-2024
  • Open
  • High
  • Low
  • Previous Close
  •  111.26
  •  112.50
  •  108.26
  •  111.26
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  106837
  •  117.82
  •  131.40
  •  89.50

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 534.77
  • 33.11
  • 10
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 626.30
  • N/A
  • 2.20

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 33.26%
  • 10.10%
  • 45.48%
  • FII
  • DII
  • Others
  • 0%
  • 0.00%
  • 11.16%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 3.27
  • 5.76
  • 3.29

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 6.81
  • 12.82
  • 0.17

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • 39.21
  • 5.84

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • 28.76
  • 28.70

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • 1.72
  • 2.21

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • 9.06
  • 10.72

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Sep 24
Sep 23
Var%
Jun 24
Jun 23
Var%
Mar 24
Mar 23
Var%
Dec 23
Dec 22
Var%
Net Sales
92.14
85.83
7.35%
81.82
67.44
21.32%
117.86
105.41
11.81%
96.29
100.97
-4.64%
Expenses
82.61
76.50
7.99%
73.79
62.61
17.86%
102.22
89.96
13.63%
84.76
87.88
-3.55%
EBITDA
9.53
9.32
2.25%
8.04
4.83
66.46%
15.65
15.45
1.29%
11.53
13.09
-11.92%
EBIDTM
10.34%
10.86%
9.82%
7.16%
13.28%
14.66%
11.98%
12.97%
Other Income
1.32
1.42
-7.04%
1.00
1.12
-10.71%
1.53
0.69
121.74%
1.11
2.40
-53.75%
Interest
2.89
1.22
136.89%
2.86
1.73
65.32%
2.28
1.27
79.53%
1.70
1.62
4.94%
Depreciation
5.00
4.09
22.25%
4.94
4.03
22.58%
3.90
4.93
-20.89%
3.94
3.90
1.03%
PBT
2.96
5.44
-45.59%
1.23
0.19
547.37%
11.00
9.95
10.55%
7.02
9.98
-29.66%
Tax
0.58
1.29
-55.04%
0.34
-0.04
-
2.91
2.71
7.38%
2.23
3.38
-34.02%
PAT
2.38
4.15
-42.65%
0.90
0.23
291.30%
8.09
7.24
11.74%
4.79
6.60
-27.42%
PATM
2.58%
4.83%
1.10%
0.34%
6.86%
6.87%
4.97%
6.54%
EPS
0.49
0.85
-42.35%
0.18
0.05
260.00%
1.66
1.49
11.41%
0.98
1.35
-27.41%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Net Sales
388.11
367.42
398.53
333.43
307.26
277.74
335.37
272.80
235.01
268.51
266.33
Net Sales Growth
7.91%
-7.81%
19.52%
8.52%
10.63%
-17.18%
22.94%
16.08%
-12.48%
0.82%
 
Cost Of Goods Sold
178.73
171.44
198.83
160.35
158.63
143.14
159.51
140.89
119.96
157.72
181.51
Gross Profit
209.38
195.98
199.69
173.08
148.63
134.60
175.86
131.91
115.04
110.79
84.82
GP Margin
53.95%
53.34%
50.11%
51.91%
48.37%
48.46%
52.44%
48.35%
48.95%
41.26%
31.85%
Total Expenditure
343.38
326.09
346.54
292.45
267.50
255.13
293.34
238.02
203.53
239.32
244.95
Power & Fuel Cost
-
13.47
11.09
9.14
7.04
7.47
7.19
5.75
5.35
6.40
6.33
% Of Sales
-
3.67%
2.78%
2.74%
2.29%
2.69%
2.14%
2.11%
2.28%
2.38%
2.38%
Employee Cost
-
53.34
49.32
40.07
35.76
35.35
48.26
40.80
33.00
30.70
23.26
% Of Sales
-
14.52%
12.38%
12.02%
11.64%
12.73%
14.39%
14.96%
14.04%
11.43%
8.73%
Manufacturing Exp.
-
39.34
33.83
29.03
23.40
26.97
13.62
7.82
7.76
7.25
7.18
% Of Sales
-
10.71%
8.49%
8.71%
7.62%
9.71%
4.06%
2.87%
3.30%
2.70%
2.70%
General & Admin Exp.
-
17.98
19.55
15.82
10.72
11.61
14.53
10.85
10.30
8.61
6.21
% Of Sales
-
4.89%
4.91%
4.74%
3.49%
4.18%
4.33%
3.98%
4.38%
3.21%
2.33%
Selling & Distn. Exp.
-
24.48
27.94
32.70
27.96
24.51
45.61
28.22
22.53
22.04
16.70
% Of Sales
-
6.66%
7.01%
9.81%
9.10%
8.82%
13.60%
10.34%
9.59%
8.21%
6.27%
Miscellaneous Exp.
-
6.04
5.98
5.35
3.98
6.07
4.62
3.69
4.62
6.60
16.70
% Of Sales
-
1.64%
1.50%
1.60%
1.30%
2.19%
1.38%
1.35%
1.97%
2.46%
1.41%
EBITDA
44.75
41.33
51.99
40.98
39.76
22.61
42.03
34.78
31.48
29.19
21.38
EBITDA Margin
11.53%
11.25%
13.05%
12.29%
12.94%
8.14%
12.53%
12.75%
13.40%
10.87%
8.03%
Other Income
4.96
5.18
6.41
4.40
2.34
4.52
2.05
3.42
5.51
3.91
2.48
Interest
9.73
6.92
5.58
8.31
10.90
12.65
10.59
9.34
10.47
13.65
10.32
Depreciation
17.78
15.95
17.47
16.03
15.79
14.41
11.42
9.79
9.02
8.76
7.13
PBT
22.21
23.64
35.35
21.04
15.41
0.07
22.07
19.07
17.50
10.69
6.41
Tax
6.06
6.40
10.92
6.49
2.91
-3.23
6.73
5.83
-1.09
0.26
-5.00
Tax Rate
27.29%
27.07%
30.89%
30.85%
28.45%
-4614.29%
30.49%
23.39%
-6.23%
4.85%
18.79%
PAT
16.16
17.25
24.43
14.55
7.32
3.30
15.34
19.11
18.59
5.10
-21.61
PAT before Minority Interest
16.16
17.25
24.43
14.55
7.32
3.30
15.34
19.11
18.59
5.10
-21.61
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
PAT Margin
4.16%
4.69%
6.13%
4.36%
2.38%
1.19%
4.57%
7.01%
7.91%
1.90%
-8.11%
PAT Growth
-11.31%
-29.39%
67.90%
98.77%
121.82%
-78.49%
-19.73%
2.80%
264.51%
-
 
EPS
3.32
3.54
5.02
2.99
1.50
0.68
3.15
3.92
3.82
1.05
-4.44

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Shareholder's Funds
238.75
200.35
175.71
160.75
153.82
151.12
136.60
118.33
98.96
94.21
Share Capital
48.73
48.73
16.24
16.24
16.18
16.12
8.06
8.03
8.00
8.00
Total Reserves
190.02
151.62
159.47
144.51
137.28
133.77
127.95
109.59
90.34
86.21
Non-Current Liabilities
48.65
30.45
20.01
19.40
22.72
20.19
16.61
18.09
34.75
37.59
Secured Loans
35.60
24.62
18.92
21.83
27.01
19.14
15.91
26.75
33.98
36.77
Unsecured Loans
0.00
0.00
0.00
0.00
0.41
3.02
4.37
0.77
0.77
0.82
Long Term Provisions
0.00
0.00
0.00
0.01
0.00
0.10
0.00
0.00
0.00
0.00
Current Liabilities
159.43
110.79
147.37
142.04
143.44
156.40
141.40
113.21
123.65
134.38
Trade Payables
62.38
58.24
81.07
64.87
66.00
71.95
66.26
45.05
46.97
64.12
Other Current Liabilities
41.21
29.07
44.71
31.16
26.68
38.65
25.15
18.33
16.71
17.24
Short Term Borrowings
55.04
22.88
17.34
44.60
49.69
40.15
49.56
46.70
56.30
51.42
Short Term Provisions
0.80
0.59
4.24
1.40
1.06
5.65
0.43
3.14
3.68
1.61
Total Liabilities
446.83
341.59
343.09
322.19
319.98
327.71
294.61
249.63
257.36
266.18
Net Block
160.83
108.66
105.64
106.52
115.92
106.01
94.16
88.75
92.19
87.11
Gross Block
266.57
198.66
180.24
165.49
159.23
135.67
112.90
97.77
120.36
107.50
Accumulated Depreciation
105.74
90.01
74.60
58.97
43.31
29.66
18.74
9.02
28.17
20.39
Non Current Assets
219.17
150.63
129.49
130.43
137.94
132.39
121.68
95.86
102.02
96.71
Capital Work in Progress
42.28
26.99
11.74
10.68
9.62
13.32
8.29
3.82
2.93
5.62
Non Current Investment
0.05
0.05
0.05
0.05
0.05
0.05
0.05
0.05
0.05
0.05
Long Term Loans & Adv.
15.71
14.41
11.78
11.32
10.40
11.72
17.33
2.35
6.36
3.65
Other Non Current Assets
0.31
0.52
0.28
1.85
1.95
1.29
1.84
0.87
0.48
0.28
Current Assets
227.65
190.95
213.59
191.76
182.03
195.32
172.94
153.77
155.34
169.46
Current Investments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Inventories
81.26
53.71
75.28
54.35
56.39
55.05
51.56
35.47
37.72
46.10
Sundry Debtors
100.17
95.25
89.52
72.25
67.93
93.10
89.22
88.18
88.53
81.29
Cash & Bank
10.46
7.52
4.97
8.35
3.95
2.94
3.53
5.61
6.39
7.69
Other Current Assets
35.75
2.56
1.41
1.55
53.76
44.23
28.63
24.52
22.70
34.39
Short Term Loans & Adv.
33.46
31.91
42.41
55.26
52.16
42.83
27.51
23.51
21.49
33.92
Net Current Assets
68.22
80.16
66.23
49.72
38.60
38.92
31.54
40.56
31.69
35.09
Total Assets
446.82
341.58
343.08
322.19
319.97
327.71
294.62
249.63
257.36
266.17

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Cash From Operating Activity
16.28
38.17
49.21
31.85
21.92
34.94
36.68
32.07
21.94
PBT
23.64
35.35
21.04
15.41
0.07
22.07
24.94
17.50
5.36
Adjustment
22.01
22.16
22.01
25.79
26.25
23.82
12.84
20.78
29.04
Changes in Working Capital
-26.79
-12.19
6.58
-8.24
0.56
-9.64
2.96
-3.72
-11.32
Cash after chg. in Working capital
18.86
45.32
49.64
32.96
26.87
36.25
40.73
34.56
23.08
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-2.58
-7.15
-0.43
-1.11
-4.96
-1.31
-4.06
-2.49
-1.14
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-73.01
-36.20
-14.57
-5.88
-19.41
-20.68
-25.83
-7.24
-11.73
Net Fixed Assets
-81.96
-32.76
-15.55
-7.23
-19.28
-22.29
-19.60
21.70
Net Investments
-0.05
0.00
-0.10
0.00
-3.54
-4.45
0.00
0.00
Others
9.00
-3.44
1.08
1.35
3.41
6.06
-6.23
-28.94
Cash from Financing Activity
59.53
0.55
-32.97
-25.97
-2.16
-15.16
-9.80
-25.15
-10.35
Net Cash Inflow / Outflow
2.80
2.51
1.66
0.00
0.35
-0.90
1.04
-0.32
-0.14
Opening Cash & Equivalents
6.42
3.42
1.39
1.46
0.50
1.47
0.42
0.74
0.88
Closing Cash & Equivalent
9.60
6.42
3.42
1.39
1.46
0.50
1.47
0.42
0.74

Financial Ratios

Consolidated /

Standalone
Description
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Book Value (Rs.)
49.00
41.12
36.06
32.99
94.84
92.99
84.38
73.25
61.47
58.89
ROA
4.38%
7.14%
4.37%
2.28%
1.02%
4.93%
7.02%
7.33%
1.95%
-8.12%
ROE
7.86%
13.00%
8.65%
4.66%
2.17%
10.73%
15.07%
17.21%
5.29%
-22.94%
ROCE
10.11%
16.82%
12.52%
8.70%
5.39%
14.64%
16.46%
14.20%
9.95%
-8.70%
Fixed Asset Turnover
1.58
2.10
1.93
1.89
1.88
2.70
2.60
2.21
2.43
2.56
Receivable days
97.06
84.61
88.55
83.26
105.81
99.21
118.05
133.84
112.03
107.85
Inventory Days
67.04
59.07
70.95
65.77
73.23
58.02
57.91
55.43
55.29
61.16
Payable days
128.40
127.86
166.10
150.56
175.89
88.19
86.92
85.73
87.08
96.17
Cash Conversion Cycle
35.70
15.82
-6.61
-1.53
3.15
69.04
89.04
103.54
80.25
72.85
Total Debt/Equity
0.44
0.30
0.29
0.50
0.59
0.52
0.60
0.68
0.98
0.99
Interest Cover
4.41
7.34
3.53
1.94
1.01
3.08
3.67
2.67
1.39
-1.58

Annual Reports:

FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
FY 2019
FY 2018
FY 2017
FY 2016

News Update:


  • Zim Laboratories - Quarterly Results
    9th Nov 2024, 19:36 PM

    Read More
  • ZIM Laboratories gets nod to invest in equity shares of SIA ZIM Laboratories
    1st Oct 2024, 14:24 PM

    The Board of Directors in their meeting held on September 30, 2024 have considered and inter alia approved the same

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.